These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38072426)

  • 1. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].
    Ohara K; Tsuge N; Watanabe S; Eda H; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Rinsho Ketsueki; 2023; 64(11):1410-1414. PubMed ID: 38072426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
    Nishina S; Tomiyama Y; Ikuta K; Tatsumi Y; Toki Y; Kato A; Kato K; Yoshioka N; Sasaki K; Hara Y; Hino K
    BMC Gastroenterol; 2021 Mar; 21(1):111. PubMed ID: 33673803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
    Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
    Viveiros A; Panzer M; Baumgartner N; Schaefer B; Finkenstedt A; Henninger B; Theurl I; Nachbaur K; Weiss G; Haubner R; Decristoforo C; Tilg H; Zoller H
    Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
    Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
    Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 70-year-old Woman with Asymptomatic Ferroportin Disease.
    Ishikawa T; Tatsumi Y; Kato K; Hayashi Y; Imai N; Ito T; Ishizu Y; Ishigami M; Nihei W; Kato A; Hayashi H
    Intern Med; 2024 Sep; 63(17):2421-2425. PubMed ID: 38296485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited iron overload disorders.
    Piperno A; Pelucchi S; Mariani R
    Transl Gastroenterol Hepatol; 2020; 5():25. PubMed ID: 32258529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperferritinemia - investigation, diagnosis and treatment].
    Melas N; Stål P
    Lakartidningen; 2024 Oct; 121():. PubMed ID: 39411810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of iron overload].
    Ruivard M; Lobbes H
    Rev Med Interne; 2023 Dec; 44(12):656-661. PubMed ID: 37507250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
    Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
    Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
    Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
    Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
    Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
    Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroportin disease: pathogenesis, diagnosis and treatment.
    Pietrangelo A
    Haematologica; 2017 Dec; 102(12):1972-1984. PubMed ID: 29101207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Theurl M; Lederer D; Haufe H; Dietze O; Strasser M; Datz C; Weiss G
    Am J Clin Nutr; 2008 May; 87(5):1374-83. PubMed ID: 18469261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia.
    Bhuva M; Patterson I; Godfrey EM; Bowden DJ; Griffiths WJH
    Dig Dis Sci; 2023 Jun; 68(6):2704-2709. PubMed ID: 36929239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.